Facioscapulohumeral muscular dystrophy (FSHD): treatment
Written and reviewed by Dr Ibrahim Imam, Consultant Neurologist. Last reviewed .
Facioscapulohumeral muscular dystrophy (FSHD): treatment. Non-steroidal anti-inflammatory drugs (NSAIDs). Fully referenced neurology checklist.
Pain
- Non-steroidal anti-inflammatory drugs (NSAIDs)
- Antidepressants: if pain is severe
Bulbar functions
Locked: subscribe to see this section.
Exposure keratitis prevention
Locked: subscribe to see this section.
Abdominal weakness
Locked: subscribe to see this section.
Respiratory insufficiency
Locked: subscribe to see this section.
Foot drop
Locked: subscribe to see this section.
Scapular stabilisation
Locked: subscribe to see this section.
Exercise
Locked: subscribe to see this section.
Investigational treatments
Locked: subscribe to see this section.
References
- Pandya S, King WM, Tawil R. Facioscapulohumeral dystrophy. Phys Ther 2008; 88:105-113.
- Tawil R. Facioscapulohumeral muscular dystrophy. Neurotherapeutics 2008; 5:601-606.
- Leung DG, Wagner KR. Therapeutic advances in muscular dystrophy. Ann Neurol 2013; 74:404-411.
- Lu J, Yao Z, Yang Y, Zhang C, Zhang J, Zhang Y. Management strategies in facioscapulohumeral muscular dystrophy. Intractable Rare Dis Res 2019; 8:9-13.
- Tawil R, Kissel JT, Heatwole C, et al; Practice Issues Review Panel of the American Association of Neuromuscular & Electrodiagnostic Medicine. Evidence-based guideline summary: evaluation, diagnosis, and management of facioscapulohumeral muscular dystrophy. Neurology 2015; 85:357-364.
- And 1 more. Subscribe to see the full list
Related checklists
- Facioscapulohumeral muscular dystrophy (FSHD): genetic classification
- Facioscapulohumeral muscular dystrophy (FSHD): clinical features
- Facioscapulohumeral muscular dystrophy (FSHD): variant phenotypes
- Facioscapulohumeral muscular dystrophy type 2 (FSHD 2)
- Facioscapulohumeral muscular dystrophy (FSHD): investigations